Post by Merck

Name: We're proud of today’s #FDA approval of new combination options for certain patients with earlier-st
Uploaded: 2026-06-12T20:16:48.853Z
Channel: Merck
Description: We're proud of today’s #FDA approval of new combination options for certain patients with earlier-stage #kidneycancer, who may face the possibility of their kidney cancer recurring after surgery. Lear

2,740,733 followers

We're proud of today’s #FDA approval of new combination options for certain patients with earlier-stage #kidneycancer, who may face the possibility of their kidney cancer recurring after surgery. Learn more: https://go.merck.com/~p8f

Video Content